LCM
PFE icon

Lynwood Capital Management’s Pfizer PFE Stock Holding History

Lynwood Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$41.7K Buy
+1,502
New +$41.7K 0.25% 31
2023
Q3 		– Sell
-50,000
Closed -$1.83M – 105
2023
Q2 		$1.83M Buy
+50,000
New +$1.95M 2.32% 10

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lynwood Capital Management's PFE Position: Q1 2024 in Review

Lynwood Capital Management opened a new position in Pfizer (PFE) in Q1 2024: 1,502 shares worth $41.7K. The stake represents 0.25% of the portfolio and ranks #31 among its holdings. This is a return to the name: Lynwood Capital Management previously reported a position in PFE as recently as Q2 2023.

Lynwood Capital Management first reported a position in PFE in Q2 2023 and has held it in 2 quarters since. The position peaked at $1.83M in Q2 2023. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Lynwood Capital Management held 1,502 shares of Pfizer worth $41.7K as of Q1 2024.
  • Pfizer was a new Lynwood Capital Management position in Q1 2024.
  • Pfizer made up 0.25% of Lynwood Capital Management's portfolio in Q1 2024, its #31 holding.
  • Lynwood Capital Management first reported a position in Pfizer in Q2 2023 and has held it in 2 quarters since.
  • Lynwood Capital Management's Pfizer position peaked at $1.83M in Q2 2023.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Lynwood Capital Management's 13F filing for Q1 2024, filed 10 May 2024.